Intermittent fasting promotes fat loss with lean mass retention, increased hypothalamic norepinephrine content, and increased neuropeptide Y gene expression in diet-induced obese male mice

Endocrinology

Volumn 157, Issue 2, 2016, Pages 679-691

  Gotthardt, Juliet D ^a   Verpeut, Jessica L ^a,b   Yeomans, Bryn L ^a   Yang, Jennifer A ^a,b   Yasrebi, Ali ^a   Roepke, Troy A ^a,b,c   Bello, Nicholas T ^a,b,c  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c the State University of New Jersey   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; LEPTIN; NEUROPEPTIDE Y; NORADRENALIN; MESSENGER RNA;

ANIMAL EXPERIMENT; ARCUATE NUCLEUS; AREA UNDER THE CURVE; ARTICLE; BODY COMPOSITION ANALYZER; BODY FAT; BODY WEIGHT; CALORIC INTAKE; CONTROLLED STUDY; DIET INDUCED OBESITY; DIET RESTRICTION; FAT MASS; GENE EXPRESSION; GLUCOSE TOLERANCE; HYPOTHALAMIC TISSUE; HYPOTHALAMUS; INSULIN TOLERANCE TEST; INTERMITTENT FASTING; LIPID DIET; LOW FAT DIET; LUNG GAS EXCHANGE; MALE; MEDIOBASAL HYPOTHALAMUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; WEIGHT REDUCTION; ADIPOSE TISSUE; ANIMAL; ANTERIOR HYPOTHALAMIC NUCLEUS; C57BL MOUSE; GENETICS; GLUCOSE TOLERANCE TEST; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; OBESITY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADIPOSE TISSUE; ANIMALS; ANTERIOR HYPOTHALAMIC NUCLEUS; ARCUATE NUCLEUS OF HYPOTHALAMUS; BODY WEIGHT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIET, HIGH-FAT; FASTING; GENE EXPRESSION; GLUCOSE TOLERANCE TEST; HYPOTHALAMUS; MALE; MICE; MICE, INBRED C57BL; NEUROPEPTIDE Y; NOREPINEPHRINE; OBESITY; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; WEIGHT LOSS;

EID: 84956877188     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2015-1622     Document Type: Article

References (59)

1. Gudzune KA, Doshi RS, Mehta AK, et al. Efficacy of commercial weight-loss programs: an updated systematic review. Ann Intern Med. 2015;162:501-512.
2. Julia C, Peneau S, Andreeva VA, et al. Weight-loss strategies used by the general population: how are they perceived? PloS One. 2014;9: e97834.
3. McAllister EJ, Dhurandhar NV, Keith SW, et al. Ten putative contributors to the obesity epidemic. Crit Rev Food Sci Nutr. 2009;49: 868-913.
4. Johnstone A. Fasting for weight loss: an effective strategy or latest dieting trend? Int J Obes (Lond). 2015;39:727-733.
5. Harvie MN, Pegington M, Mattson MP, et al. The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Int J Obes (Lond). 2011;35:714-727.
6. Klempel MC, Kroeger CM, Varady KA. Alternate day fasting (ADF) with a high-fat diet produces similar weight loss and cardio-protection as ADF with a low-fat diet. Metabolism. 2013;62:137-143.
7. Bhutani S, Klempel MC, Kroeger CM, Trepanowski JF, Varady KA. Alternate day fasting and endurance exercise combine to reduce body weight and favorably alter plasma lipids in obese humans. Obesity. 2013;21:1370-1379.
8. Hoddy KK, Kroeger CM, Trepanowski JF, Barnosky AR, Bhutani S, Varady KA. Safety of alternate day fasting and effect on disordered eating behaviors. Nutr J. 2015;14:44.
9. Klempel MC, Kroeger CM, Bhutani S, Trepanowski JF, Varady KA. Intermittent fasting combined with calorie restriction is effective for weight loss and cardio-protection in obese women. Nutr J. 2012; 11:98.
10. Varady KA, Bhutani S, Church EC, Klempel MC. Short-term modified alternate-day fasting: a novel dietary strategy for weight loss and cardioprotection in obese adults. Am J Clin Nutr. 2009;90: 1138-1143.
11. Varady KA, Bhutani S, Klempel MC, et al. Alternate day fasting for weight loss in normal weight and overweight subjects: a randomized controlled trial. Nutr J. 2013;12:146.
12. Eshghinia S, Mohammadzadeh F. The effects of modified alternateday fasting diet on weight loss and CAD risk factors in overweight and obese women. J Diabetes Metab Disord. 2013;12:4.
13. Johnson JB, Summer W, Cutler RG, et al. Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma. Free Radic Biol Med. 2007;42:665-674.
14. Heilbronn LK, Smith SR, Martin CK, Anton SD, Ravussin E. Alternate-day fasting in nonobese subjects: effects on body weight, body composition, and energy metabolism. Am J Clin Nutr. 2005; 81:69-73.
15. Itoi K, Sugimoto N. The brainstem noradrenergic systems in stress, anxiety and depression. J Neuroendocrinol. 2010;22:355-361.
16. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW. Central nervous system control of food intake and body weight. Nature. 2006;443:289-295.
17. Sobrino Crespo C, Perianes Cachero A, Puebla Jimenez L, Barrios V, Arilla Ferreiro E. Peptides and food intake. Front Endocrinol. 2014; 5:58.
18. Choi YH, Hartzell D, Azain MJ, Baile CA. TRH decreases food intake and increases water intake and body temperature in rats. Physiol Behav. 2002;77:1-4.
19. Krahn DD, Gosnell BA, Levine AS, Morley JE. Behavioral effects of corticotropin-releasing factor: localization and characterization of central effects. Brain Res. 1988;443:63-69.
20. Lin S, Storlien LH, Huang XF. Leptin receptor, NPY, POMCmRNA expression in the diet-induced obese mouse brain. Brain Res. 2000; 875:89-95.
21. Ma Y, Bertone ER, Stanek EJ 3rd, et al. Association between eating patterns and obesity in a free-living US adult population. Am J Epidemiol. 2003;158:85-92.
22. Molnar D, Jeges S, Erhardt E, Schutz Y. Measured and predicted resting metabolic rate in obese and nonobese adolescents. J Pediatr. 1995;127:571-577.
23. Inui A, Asakawa A, Bowers CY, et al. Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ. FASEB J. 2004;18:439-456.
24. Moran TH. Gut peptide signaling in the controls of food intake. Obesity. 2006;51(suppl 4):250S-253S.
25. Schwartz MW, Woods SC, PorteDJr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature. 2000;404:661-671.
26. Williams KW, Elmquist JK. From neuroanatomy to behavior: central integration of peripheral signals regulating feeding behavior. Nat Neurosci. 2012;15:1350-1355.
27. Anson RM, Guo Z, de Cabo R, et al. Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake. Proc Natl Acad Sci USA. 2003;100:6216-6220.
28. Wan R, Camandola S, Mattson MP. Intermittent food deprivation improves cardiovascular and neuroendocrine responses to stress in rats. Nutr J. 2003;133:1921-1929.
29. Martin B, Pearson M, Kebejian L, et al. Sex-dependent metabolic, neuroendocrine, and cognitive responses to dietary energy restriction and excess. Endocrinology. 2007;148:4318-4333.
30. Vasconcelos AR, Yshii LM, Viel TA, et al. Intermittent fasting attenuates lipopolysaccharide-induced neuroinflammation and memory impairment. J Neuroinflamm. 2014;11:85.
31. Li L, Wang Z, Zuo Z. Chronic intermittent fasting improves cognitive functions and brain structures in mice. PloS One. 2013;8: e66069.
32. Varady KA, Roohk DJ, Bruss M, Hellerstein MK. Alternate-day fasting reduces global cell proliferation rates independently of dietary fat content in mice. Nutrition. 2009;25:486-491.
33. Wan R, Ahmet I, Brown M, et al. Cardioprotective effect of intermittent fasting is associated with an elevation of adiponectin levels in rats. J Nutr Biochem. 2010;21:413-417.
34. Buettner R, Scholmerich J, Bollheimer LC. High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity. 2007; 15:798-808.
35. Verpeut JL, Walters AL, Bello NT. Citrus aurantium and Rhodiola rosea in combination reduce visceral white adipose tissue and increase hypothalamic norepinephrine in a rat model of diet-induced obesity. Nutr Res. 2013;33:503-512.
36. Franklin KB, Paxinos G. The Mouse Brain in Stereotaxic Coordinates, Compact. The Coronal Plates and Diagrams. 3rd ed. Amsterdam: Elsevier Academic Press; 2008.
37. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-δδC[T]) method. Methods. 2001;25:402-408.
38. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29:e45.
39. Tschop MH, Speakman JR, Arch JR, et al. A guide to analysis of mouse energy metabolism. Nat Methods. 2012;9:57-63.
40. Barnosky AR, Hoddy KK, Unterman TG, Varady KA. Intermittent fasting vs daily calorie restriction for type 2 diabetes prevention: a review of human findings. Transl Res. 2014;164:302-311.
41. Chausse B, Solon C, Caldeira da Silva CC, et al. Intermittent fasting induces hypothalamic modifications resulting in low feeding efficiency, low body mass and overeating. Endocrinology. 2014;155: 2456-2466.
42. Martin B, Pearson M, Brenneman R, et al. Conserved and differential effects of dietary energy intake on the hippocampal transcriptomes of females and males. PloS One. 2008;3:e2398.
43. Rinaman L. Hindbrain noradrenergic A2 neurons: diverse roles in autonomic, endocrine, cognitive, and behavioral functions. Am J Physiol Regul Integr Comp Physiol. 2011;300:R222-R235.
44. Ritter S, Dinh TT, Li AJ. Hindbrain catecholamine neurons control multiple glucoregulatory responses. Physiol Behav. 2006;89:490-500.
45. Sergeyev V, Broberger C, Gorbatyuk O, Hokfelt T. Effect of 2-mercaptoacetate and 2-deoxy-D-glucose administration on the expression of NPY, AGRP, POMC, MCHand hypocretin/orexin in the rat hypothalamus. Neuroreport. 2000;11:117-121.
46. Fraley GS, Dinh TT, Ritter S. Immunotoxic catecholamine lesions attenuate 2DG-induced increase of AGRP mRNA. Peptides. 2002; 23:1093-1099.
47. Fraley GS, Ritter S. Immunolesion of norepinephrine and epinephrine afferents to medial hypothalamus alters basal and 2-deoxy-Dglucose-induced neuropeptide Y and agouti gene-related protein messenger ribonucleic acid expression in the arcuate nucleus. Endocrinology. 2003;144:75-83.
48. Ozawa Y, Arima H, Watanabe M, et al. Repeated glucoprivation delayed hyperphagic responses while activating neuropeptide Yneurons in rats. Peptides. 2011;32:763-769.
49. Betley JN, Xu S, Cao ZF, et al. Neurons for hunger and thirst transmit a negative-valence teaching signal. Nature. 2015;521:180-185.
50. Hahn TM, Breininger JF, Baskin DG, Schwartz MW. Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nat Neurosci. 1998;1:271-272.
51. Palou M, Sanchez J, Rodriguez AM, Priego T, Pico C, Palou A. Induction of NPY/AgRP orexigenic peptide expression in rat hypothalamus is an early event in fasting: relationship with circulating leptin, insulin and glucose. Cell Physiol Biochem. 2009;23:115-124.
52. Estes KS, Simpkins JW. Age-related alteration in catecholamine activity within microdissected brain regions of ovariectomized Fischer 344 rats. J Neurosci Res. 1984;11:405-417.
53. Rahmouni K, Correia ML, Haynes WG, Mark AL. Obesity-associated hypertension: new insights into mechanisms. Hypertension. 2005;45:9-14.
54. Kim MS, Yoon CY, Park KH, et al. Changes in ghrelin and ghrelin receptor expression according to feeding status. Neuroreport. 2003; 14:1317-1320.
55. Briggs DI, Enriori PJ, Lemus MB, Cowley MA, Andrews ZB. Dietinduced obesity causes ghrelin resistance in arcuate NPY/AgRP neurons. Endocrinology. 2010;151:4745-4755.
56. Date Y, Shimbara T, Koda S, et al. Peripheral ghrelin transmits orexigenic signals through the noradrenergic pathway from the hindbrain to the hypothalamus. Cell Metab. 2006;4:323-331.
57. Cowley MA, Smith RG, Diano S, et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron. 2003;37: 649-661.
58. Lu S, Guan JL, Wang QP, et al. Immunocytochemical observation of ghrelin-containing neurons in the rat arcuate nucleus. Neurosci Lett. 2002;321:157-160.
59. Sato T, Fukue Y, Teranishi H, Yoshida Y, Kojima M. Molecular forms of hypothalamic ghrelin and its regulation by fasting and 2-deoxy-d-glucose administration. Endocrinology. 2005;146:2510-2516.